2-(二甲基氨基甲酰基)苯甲酸 | 20320-37-0

• 物质功能分类: 分析化学 - 标准品 - 药典标准品和杂质标准品
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(二甲基氨基甲酰基)苯甲酸
• 中文别名: 2-(二甲基氨基甲酰基)安息香酸
• 英文名称: 2-(dimethylaminocarbonyl)benzoic acid
• 英文别名: N,N-dimethylphthalamic acid；N,N-dimethyl-phthalamic acid；N,N-Dimethyl-phthalamidsaeure；o-dimethylcarbamoylbenzoic acid；Phthalsaeure-mono-(dimethylamid)；N,N-Dimethylphthalamidsaeure；2-(Dimethylcarbamoyl)benzoic acid
• CAS: 20320-37-0
• 化学式: C₁₀H₁₁NO₃
• mdl: MFCD01755760
• 分子量: 193.202
• InChiKey: MMJYFEBZBADSNQ-UHFFFAOYSA-N

物化性质

• 熔点：
  124-125 °C
• 沸点：
  389.3±25.0 °C(Predicted)
• 密度：
  1.228±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(二甲基氨基甲酰基)苯甲酸 在 氯化亚砜 作用下， 生成 N-甲基邻苯二甲酰亚胺
  参考文献：
  名称：

  Horak; Novotny, Collection of Czechoslovak Chemical Communications, 1953, vol. 18, p. 80,83

  摘要：

  DOI：
• 作为产物：
  描述：

  2-碘苯甲酸 在 氯化亚砜 作用下， 以 二氯甲烷 、 氯仿 、 水 为溶剂， 68.0 ℃ 、140.0 kPa 条件下， 反应 79.5h， 生成 苯酐 、 2-(二甲基氨基甲酰基)苯甲酸
  参考文献：
  名称：

  Reactivity of Ortho-Palladated Benzamides toward CO, Isocyanides, and Alkynes. Synthesis of Functionalized Isoindolin-1-ones and 4,5-Disubstituted Benzo[c]azepine-1,3-diones

  摘要：

  Aryl palladium complexes [Pd{C6H4C(O)NRR'-2}I(tmeda)] [NRR' = NH2 (1a), NHMe (1b), NMe2 (1c); tmeda = N,N,N',N'-tetramethylethylenediamine] are prepared by oxidative addition of the corresponding 2-iodophenylbenzamides to Pd(dba)(2) ([Pd-2(dba)(3)]center dot dba; dba = dibenzylideneacetone) in the presence of tmeda. Cationic cyclometalated derivatives [Pd{'2C,O-C6H4C(O)NRR'-2}(tmeda)]TfO (2ac) are obtained by iodide abstraction from the appropriate complex 1 with AgTfO, while the deprotonation of the amide function of 1a or 1b with KOtBu gives the neutral amidate complexes [Pd{'2C,N-C6H4C(O)NR-2}(tmeda)] [R = H (3a), Me (3b)]. Complexes 2a,b and 3a,b react with CO under mild conditions to yield phthalimide (4a) or N-methylphthalimide (4b), whereas the reactions of derivatives 1c and 2c with CO are very slow and give N-1,N-1,N-2,N-2-tetramethylphthalamide and phthalic anhydride. The reaction of 1b with 1 equiv of XyNC (Xy = 2,6-dimethylphenyl) or tBuNC affords Pd(0), (tmedaH)I, and 3-(2,6-dimethylphenylimino)-2-methylisoindolin-1-one (5b) or 3-(tert-butylimino)-2-methylisoindolin-1-one (5b'), respectively, while complex 1c reacts with 3 equiv of XyNC to give trans-[Pd{C('NXy)C6H4C(O)NMe2-2}I(CNXy)(2)] (6). The seven-membered palladacycles [Pd{'2C,O-C(X)'C(X')C6H4C(O)NRR'-2}(tmeda)]TfO [NRR' = NH2 and X = Ph, X' = Me (7a); NRR' = NHMe and X = Ph, X' = Me (7b), X = X' = Ph (8b), Et (9b), CO2Me (10b), X = CO2Me, X' = Ph (11b), X = CO2Et, X' = Ph (12b); NRR' = NMe2 and X = X' = Ph (8c), Et (9c)] are obtained from the reactions of 2ac with alkynes. Treatment of complexes 7a, 7b, 8b, and 9b with CO at room temperature gives the corresponding 2H-benzo[c]azepine-1,3-diones (14), resulting from the insertion of a molecule of CO into the PdC bond followed by a CN reductive coupling. In contrast, the reactions of 11b or 12b with CO in the presence of residual water or 2 equiv of ROH (R = Me, Et) lead to 2-methyl-3-phenylisoindolin-1-one derivatives (15), resulting from a CO insertion followed by an intramolecular aza-Michael addition of the NHMe moiety to the activated vinyl group and subsequent hydrolysis or alcoholysis of the acylPd bond. The neutral complex [Pd('2C,O-C14H13O5)(tmeda)] (18) was synthesized by reacting the cationic derivative 10b with NaOMe in MeOH. Depalladation of 18 gives (E)-4-[methoxy(methoxycarbonyl)methylene]-2-methylisoquinoline-1,3(2H,4H)-dione (19).

  DOI：

  10.1021/om4006406

文献信息

• [EN] KCNT1 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS DE KCNT1 ET PROCÉDÉS D'UTILISATION
  申请人：PRAXIS PREC MEDICINES INC

  公开号：WO2020227097A1

  公开（公告）日：2020-11-12

  The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.

  本发明部分涉及用于预防和/或治疗神经系统疾病或紊乱、与过度神经元兴奋性有关的疾病或症状，以及基因中的功能增强突变（例如，KCNT1）的化合物和组合物。本文还提供了治疗神经系统疾病或紊乱、与过度神经元兴奋性有关的疾病或症状，以及基因中的功能增强突变（如KCNT1）的方法。
• Preparation of 13-Substituted 8<i>H</i>-Dibenzo[<i>a</i>,<i>g</i>]quinolizin-8-ones by Intramolecular Wittig-Horner Reaction of Dialkyl 2-(<i>o</i>-Acylbenzoyl)-1,2-dihydro-1-isoquinolylphosphonates
  作者：Kin-ya Akiba、Yoshio Negishi、Naoki Inamoto

  DOI：10.1246/bcsj.57.2188

  日期：1984.8

  Dialkyl 2-(o-acylbenzoyl)-1,2-dihydro-1-isoquinolyl-phosphonates (1) were prepared by reactions of isoquinoline, o-acylbenzoyl chloride, and trialkyl phosphites. Treatment of 1 with lithium diisopr...

  二烷基 2-(o-酰基苯甲酰基)-1,2-二氢-1-异喹啉基膦酸酯 (1) 通过异喹啉、邻酰基苯甲酰氯和亚磷酸三烷基酯的反应制备。用锂离子分散剂处理1...
• Pyridyl-substituted imidazoles, compositions containing same and methods
  申请人：Tanabe Seiyaku Company, Ltd.

  公开号：US04996217A1

  公开（公告）日：1991-02-26

  Novel imidazole of the formula: ##STR1## wherein Ring A is pyridyl group or a substituted pyridyl group; Ring B is phenyl group or a substituted phenyl group; R.sup.1 and R.sup.2 are hydrogen atom or are combined together to form a group of the formula: --(CH.sub.2).sub.q --; m is 1 or 2; n is 0, 1 or 2; and q is 3 or 4, or a salt thereof are disclosed. Said derivative (I) and a salt thereof are useful as anti-ulcer agents.

  式（I）所示的新咪唑化合物：##STR1##其中，环A为吡啶基或取代的吡啶基；环B为苯基或取代的苯基；R1和R2为氢原子或结合在一起形成式--（CH2）q--的基团；m为1或2；n为0、1或2；q为3或4，或其盐被公开。所述衍生物（I）及其盐可作为抗溃疡剂使用。
• [EN] SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS<br/>[FR] PYRAZOLOAZÉPIN-4-ONES SUBSTITUÉES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PHOSPHODIESTÉRASE
  申请人：LEO PHARMA AS

  公开号：WO2018108230A1

  公开（公告）日：2018-06-21

  The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.

  本发明涉及具有磷酸二酯酶抑制活性的新型取代吡唑啉-4-酮化合物，以及它们作为治疗炎症性疾病和症状的治疗剂的用途。
• Synthesis of 2-phenylthiazolidine derivatives as cardiotonic agents. I. 2-Phenylthiazolidine-3-thiocarboxamides.
  作者：HIROYUKI NATE、YASUO SEKINE、YASUSHI HONMA、HIDEO NAKAI、HIROSHI WADA、MIKIO TAKEDA、HIDEO YABANA、TAKU NAGAO

  DOI：10.1248/cpb.35.1953

  日期：——

  A series of novel 2-phenylthiazolidine-3-thiocarboxamides (II) was synthesized and tested for positive inotropic activity in the isolated guinea pig heart and in anesthetized dogs. Reaction of the benzaldehydes (VI, XI, XIV and XV) with cysteamine followed by treatment with isothiocyanates readily gave II. Structure-activity relationships were investigated by varying the structural parameters. N-Methyl-2 -phenylthiazolidine-3-thiocarboxamides having an ortho substituent such as a Me or OMe group exhibited significant positive inotropic action, which was not blocked by propranolol. Among the various ortho-alkoxyphenyl derivatives synthesized, the 2- (2- (3- (4-phenylpiperazino) propoxy) phenyl) derivative (I67) was found to exhibit more potent and longerlasting activity than amrinone without any significant effect on heart rate or blood pressure

  一系列新型2-苯基噻唑烷-3-硫代氨基甲酸酯（II）被合成并测试了其在离体豚鼠心脏和麻醉犬中的正性肌力活性。苯甲醛（VI、XI、XIV和XV）与半胱胺反应后，再用异硫氰酸酯处理，即可得到II。通过改变结构参数来研究结构-活性关系。具有邻位取代基如Me或OMe的N-甲基-2-苯基噻唑烷-3-硫代氨基甲酸酯表现出显著的正性肌力作用，且该作用不受普萘洛尔阻断。在合成的各种邻位烷氧基苯基衍生物中，2-（2-（3-（4-苯基哌嗪）丙氧基）苯基）衍生物（I67）显示出比氨力农更强大且持久的活性，而对心率或血压无显著影响。